Sabra Healthcare REIT SBRA
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
Sabra Healthcare REIT (SBRA) Core Market Data and Business Metrics
Latest Closing Price
$17.5Price-Earnings Ratio
42.68Total Outstanding Shares
237.91 Million SharesDividend
$0.30 Per Share QuarterlySIC Description
Real Estate Investment TrustsPrimary Exchange
NASDAQHeadquarters
18500 Von Karman, Irvine, CA, 92612
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Cash Flow Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Investing Activities | $-189.34 Million |
| Net Cash Flow From Financing Activities | $-89.96 Million |
| Net Cash Flow From Financing Activities, Continuing | $-89.96 Million |
| Net Cash Flow, Continuing | $30.01 Million |
| Exchange Gains/Losses | $108,000 |
| Net Cash Flow | $30.12 Million |
Income Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Net Income/Loss | $97.17 Million |
| Costs And Expenses | $584.93 Million |
| Income Tax Expense/Benefit | $1.12 Million |
| Basic Average Shares | $232.47 Million |
| Diluted Earnings Per Share | $0.41 |
| Preferred Stock Dividends And Other Adjustments | $0 |
Comprehensive Income
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Other Comprehensive Income/Loss | $-22.73 Million |
| Comprehensive Income/Loss Attributable To Parent | $74.44 Million |
| Comprehensive Income/Loss | $74.44 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
Balance Sheet
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Assets | $5.37 Billion |
| Liabilities | $2.62 Billion |
| Liabilities And Equity | $5.37 Billion |
| Current Liabilities | $2.62 Billion |
| Noncurrent Liabilities | $0 |
| Long-term Debt | $2.47 Billion |
Historical Dividends
Current dividend: $0.30 Per Share Quarterly
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Feb 3, 2025 | Feb 28, 2025 | Feb 14, 2025 | $0.3 | Quarterly |
| Oct 31, 2024 | Nov 29, 2024 | Nov 15, 2024 | $0.3 | Quarterly |
| Aug 7, 2024 | Aug 30, 2024 | Aug 19, 2024 | $0.3 | Quarterly |
| May 8, 2024 | May 31, 2024 | May 20, 2024 | $0.3 | Quarterly |
| Feb 1, 2024 | Feb 29, 2024 | Feb 13, 2024 | $0.3 | Quarterly |
| Nov 6, 2023 | Nov 30, 2023 | Nov 17, 2023 | $0.3 | Quarterly |